Carolina is a senior biotech executive with more than 25 years of experience in the biopharmaceutical industry in Massachusetts. She is the Founder and Principal at Bio Strategy Advisors, a strategic business consulting firm specializing in Biotech and Medtech start-up formation, corporate strategy, investor-readiness, strategic partnerships and geographical expansion. Prior to this, she was a President at Aegerion Pharmaceuticals and then a President at Novelion Therapeutics, until their respective exits. Both were commercial-stage, publicly-traded Biotech companies. Previously, Carolina was a Vice-President at Genzyme Corporation where she spent 15 years in progressive P&L leadership roles until the acquisition by Sanofi in 2011. Carolina serves on the Board of 3 private biotech companies: Syte.bio, Bonds Biosystems and Dione Antibiotics, as well as, on the Board of Advisors of Eastern Bank, a publicly traded bank in Boston. She was previously a Board member at NED Biosystems. She is an Advisory Board Member for Cell and Gene Therapy at Informa Connect Life Sciences. Carolina is a Strategic Advisors to E2MC Ventures, a VC forcused on the Space Economy, and to Interlink Markets, a boutique investment bank. Carolina is also an Angel investor and Member of Walnut Ventures, TBD Angels, The Longevity Investors Network and AccelHUB Ventures. Carolina serves in several non-profit Boards: she is a Board Member of MassBio, the Massachusetts Biotechnology Council; Latinos in Bio, which she co-founded and now co-chairs; and the Mass General Hospital Board of Trustees (MGPO). She previously served in the Latino Council at Boston Children’s Hospital and the Massachusetts STEM Advisory Council. Carolina has been recently featured in the Boston Business Journal’s Women Who Lead in the Life Sciences (October 2023), in The Boston Globe as one of Amplify LatinX 100 change-making leaders from across the commonwealth of Massachusetts (September 2023), in Boston Magazine as one of the one 150 Most Influential Bostonians (April 2023); in The Boston Globe as one of the leading faces of Biotech in Boston (March 2021); and in the Boston Business Journal as one of the Power 50 “Movement Makers” (November 2021). Carolina holds a BS in Business Administration from the University of Lima and a Graduate Degree in Business and Management from Harvard University.